Clinical Trials on Tyrosinemia, Type II in Austria
Total 3501 results
-
Swedish Orphan BiovitrumCompletedHereditary Tyrosinemia, Type IBelgium, Denmark, France, Germany, Austria, Czechia, Finland, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Spain, Sweden, United Kingdom
-
Medical University of ViennaUnknown
-
Arbeitsgemeinschaft medikamentoese TumortherapieAmgenTerminatedKRAS Wild Type | Resectable Type II Gastric AdenocarcinomaAustria
-
Medical University of GrazCompletedDiabetes Mellitus, Type IIAustria
-
Medical University of ViennaCompletedDiabetes Mellitus Type IIAustria
-
Medical University of ViennaUnknown
-
Medical University of ViennaUnknown
-
Austrian Academic Institute for Clinical NutritionMedical University of ViennaCompletedHeterozygous Familial HypercholesterolemiaAustria
-
LipimetiX Development, LLCCompletedHypercholesterolemia | Hyperlipoproteinemia Type IIAustralia
-
Medical University of ViennaUnknown
-
DyaMX Inc.Active, not recruiting
-
University of AdelaideRoyal Adelaide HospitalCompletedInsulin Resistance | Diabetes Mellitus, Type IIAustralia
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruiting
-
Medical University of ViennaRecruitingPompe Disease | McArdle DiseaseAustria
-
The University of Western AustraliaNational Health and Medical Research Council, AustraliaUnknownFamilial Hypercholesterolaemia | HypertriglyceridaemiaAustralia
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II (GSD-II) | Pompe Disease (Late-Onset) | Glycogenesis Type II | Acid Maltase Deficiency (AMD)United States, France, Canada, Netherlands, Australia
-
Regeneron PharmaceuticalsCompletedHomozygous Familial HypercholesterolemiaUnited States, Australia, Austria, Netherlands, Taiwan, Ukraine
-
Olivia Newton-John Cancer Research InstituteBristol-Myers Squibb; Barwon Health; Austin Health; Eastern Health; Fiona Stanley... and other collaboratorsRecruitingFollicular Lymphoma Stage II | Follicular Lymphoma Stage III | Follicular Lymphoma Stage IVAustralia
-
Novartis PharmaceuticalsTerminatedSporadic Superficial and Nodular Skin Basal Cell CarcinomasAustria, Australia
-
Medical University of ViennaUnknownType2 Diabetes MellitusAustria
-
Arrowhead PharmaceuticalsCompletedDyslipidemias | Hypertriglyceridemia | Familial HypercholesterolemiaAustralia, New Zealand
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II (GSD-II) | Pompe Disease | Glycogenesis 2 Acid Maltase DeficiencyUnited States, Canada, Australia
-
Pharvaris Netherlands B.V.Active, not recruitingHereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | Hereditary Angioedema Types I and II | Hereditary Angioedema Attack | Hereditary Angioedema With C1 Esterase Inhibitor Deficiency | Hereditary Angioedema - Type 1 | Hereditary Angioedema - Type 2 | C1 Esterase Inhibitor... and other conditionsUnited States, Poland, Germany, Austria, Bulgaria, Canada, Ireland, Italy, United Kingdom
-
Regeneron PharmaceuticalsCompletedHomozygous Familial HypercholesterolemiaUnited States, Netherlands, Australia, Austria, Canada, France, Greece, Italy, Japan, South Africa, Ukraine
-
Arrowhead PharmaceuticalsActive, not recruitingHomozygous Familial HypercholesterolemiaAustralia, Canada, United States, South Africa
-
Austrian Breast & Colorectal Cancer Study GroupCompleted
-
Alexion PharmaceuticalsAchillion, a wholly owned subsidiary of AlexionCompletedC3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Mediated Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis Types I, II, and IIINetherlands, Australia, Belgium
-
Medical University of ViennaAstraZenecaCompletedType2 Diabetes | Steatosis, LiverAustria
-
Regeneron PharmaceuticalsCompletedHomozygous Familial HypercholesterolemiaUnited States, Netherlands, South Africa, Australia, Austria, Canada, Czechia, France, Greece, Italy, Japan, Ukraine
-
Medical University of GrazCompletedHealthy | Obesity | Type 2 Diabetes Mellitus | Type 1 DiabetesAustria
-
SanofiTerminatedSleep Initiation and Maintenance DisordersUnited States, Canada, Brazil, Russian Federation, Australia, Germany, Italy, Spain, Turkey, India, Malaysia, Singapore, Belgium, Czech Republic, Mexico, Argentina, Austria, Colombia, Chile, South Africa, United Kingdom, Hong Kong
-
Landsteiner InstitutLund University; Medical University of Vienna; Mein Hanusch-Krankenhaus; Fondazione... and other collaboratorsCompletedType 2 Diabetes Mellitus | Insulin ResistanceAustria
-
Landsteiner InstitutMedical University of Vienna; Lund University Hospital; Mein Hanusch-Krankenhaus and other collaboratorsCompletedType 2 Diabetes MellitusAustria
-
Telix International Pty LtdRecruitingGlioblastoma | Glioblastoma Multiforme | Neoplastic DiseaseAustralia, Austria, Netherlands, New Zealand
-
Alexandra Kautzky-WillerBayerRecruitingFatty Liver | Hypogonadism, Male | Overweight/Obesity | Prediabetes/Type2 Diabetes MellitusAustria
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II;Pompe's DiseaseCzechia, Taiwan, Belgium, Germany, Korea, Republic of, United States, Argentina, Australia, Austria, Brazil, Canada, Denmark, France, Hungary, Italy, Japan, Mexico, Netherlands, Poland, Portugal, Russian Federation, Spain, Switzerland, Turk... and more
-
Telix International Pty LtdCompletedGlioblastoma MultiformeAustria, Australia, Netherlands
-
Capillary Biomedical, Inc.TerminatedType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMAustria
-
St. Anna KinderkrebsforschungMedical University of Vienna; St. Petersburg State Pavlov Medical University; National Research Center for Radiation Medicine in Kiev and other collaboratorsRecruiting
-
Paracelsus Medical UniversityCompletedType 2 Diabetes MellitusAustria
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingMalignant Melanoma Stage IIIAustria, Netherlands, Australia, Sweden
-
Ionis Pharmaceuticals, Inc.Completed
-
CeQur CorporationInternational Diabetes Center at Park NicolletCompletedType 2 Diabetes MellitusAustria
-
Medical University of ViennaUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Healthy Volunteers | Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) | Familiar Hypocalcuric HypercalcemiaAustria
-
University of AdelaideSalk Institute for Biological Studies; University of South AustraliaCompletedObesity | Type2 DiabetesAustralia
-
University of ViennaUnknownCancer | Type 2 DiabetesAustria
-
Medical University of GrazCompletedHyperglycemia | Diabetes Mellitus Type 2Austria
-
IpsenActive, not recruitingNeuroendocrine TumorsAustria, Denmark, Switzerland, Australia, United Kingdom, France
-
CeQur CorporationTerminatedType 2 Diabetes MellitusAustria
-
Medical University of GrazCompleted